Stay updated on Secukinumab Long-term Efficacy in PsA Clinical Trial
Sign up to get notified when there's something new on the Secukinumab Long-term Efficacy in PsA Clinical Trial page.

Latest updates to the Secukinumab Long-term Efficacy in PsA Clinical Trial page
- Check2 days agoChange DetectedA new page revision 3.4.2 was added, replacing 3.4.1, a minor metadata update that does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check9 days agoChange DetectedThe page shows a minor version update from v3.4.0 to v3.4.1. There are no changes to study information or its presentation.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedShow glossary added; QC metadata label updated to 'Last Update Submitted that Met QC Criteria' and No FEAR Act Data label added, while older labels and the previous revision (v3.3.4) were removed and the revision updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check30 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 removed, a minor site maintenance update with no impact on study data or user-facing content.SummaryDifference0.0%

- Check59 days agoChange DetectedLocations section updated with numerous new site entries across the United States and international regions (Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Czech Republic, and more). Several existing location entries were removed or reorganized.SummaryDifference2%

- Check80 days agoChange DetectedA minor version update is shown: Revision: v3.3.2 replacing v3.3.1, with no visible impact on page content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Secukinumab Long-term Efficacy in PsA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Secukinumab Long-term Efficacy in PsA Clinical Trial page.